Therapeutic drug monitoring of antimicrobials

被引：16
|
作者：
Balakrishnan, Indran [1 ,2 ]
Shorten, Robert J. [2 ,3 ]
机构：
[1] Royal Free London NHS Fdn Trust, Dept Med Microbiol, London, England
[2] UCL, Ctr Clin Microbiol, Royal Free Campus, London, England
[3] Manchester Royal Infirm, Publ Hlth Lab Manchester, Oxford Rd, Manchester M13 9WL, Lancs, England
来源：
ANNALS OF CLINICAL BIOCHEMISTRY | 2016年 / 53卷 / 03期
关键词：
Antimicrobial therapy; therapeutic drug monitoring; ESCHERICHIA-COLI; DISSEMINATED CANDIDIASIS; ORAL POSACONAZOLE; BRITISH SOCIETY; AMPHOTERICIN-B; PHARMACOKINETICS; VORICONAZOLE; GENTAMICIN; VANCOMYCIN; SAFETY;
D O I：
10.1177/0004563215618981
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
As pathology services become more centralized and automated, the measurement of therapeutic antimicrobial drugs concentrations is increasingly performed in clinical biochemistry or blood science' laboratories. This review outlines key groups of antimicrobial agents: aminoglycosides, glycopeptides, antifungal agents and antituberculosis agents, their role in managing infectious diseases, and the reasons why serum concentration measurement is important.
引用
收藏
页码：333 / 346
页数：14
相关论文
共 50 条
  • [21] Refining the therapeutic range of posaconazole and isavuconazole for efficient therapeutic drug monitoring using a bioassay approach
    Willeman, Theo
    Tonini, Julia
    Garnaud, Cecile
    Bailly, Sebastien
    Gandia, Peggy
    Stanke-Labesque, Francoise
    Maubon, Daniele
    Gautier-Veyret, Elodie
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2020, 34 (02) : 279 - 287
  • [22] Modulators of Very Low Voriconazole Concentrations in Routine Therapeutic Drug Monitoring
    Hassan, Arwa
    Burhenne, Juergen
    Riedel, Klaus-Dieter
    Weiss, Johanna
    Mikus, Gerd
    Haefeli, Walter E.
    Czock, David
    THERAPEUTIC DRUG MONITORING, 2011, 33 (01) : 86 - 93
  • [23] Level of Evidence for Therapeutic Drug Monitoring of Vancomycin
    Jelassi, Mohamed Larbi
    Benlmouden, Amine
    Lefeuvre, Sandrine
    Mainardi, Jean-Luc
    Billaud, Eliane M.
    THERAPIE, 2011, 66 (01): : 29 - 37
  • [24] Level of Evidence for Therapeutic Drug Monitoring of Fluconazole
    Venisse, Nicolas
    Le Guellec, Chantal
    THERAPIE, 2011, 66 (02): : 97 - 101
  • [25] Voriconazole therapeutic drug monitoring: focus on safety
    Pasqualotto, Alessandro C.
    Xavier, Melissa O.
    Andreolla, Huander F.
    Linden, Rafael
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (01) : 125 - 137
  • [26] Therapeutic Drug Monitoring (TDM) of Antimicrobial Agents
    Kim, Shin-Woo
    INFECTION AND CHEMOTHERAPY, 2008, 40 (03): : 133 - 139
  • [27] Level of Evidence for Therapeutic Drug Monitoring of Aminoglycosides
    Venisse, Nicolas
    Boulamery, Audrey
    THERAPIE, 2011, 66 (01): : 39 - 44
  • [28] Voriconazole therapeutic drug monitoring: results of a prematurely discontinued randomized multicenter trial
    Neofytos, D.
    Ostrander, D.
    Shoham, S.
    Laverdiere, M.
    Hiemenz, J.
    Nguyen, H.
    Clarke, W.
    Brass, L.
    Lu, N.
    Marr, K. A.
    TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (06) : 831 - 837
  • [29] The Clinical Significance of Voriconazole Therapeutic Drug Monitoring in Children With Invasive Fungal Infections
    Kang, Hyun Mi
    Lee, Hoan Jong
    Cho, Eun Young
    Yu, Kyung-Sang
    Lee, Hyunju
    Lee, Ji Won
    Kang, Hyoung Jin
    Park, Kyung Duk
    Shin, Hee Young
    Choi, Eun Hwa
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2015, 32 (08) : 557 - 567
  • [30] Therapeutic Drug Monitoring of Voriconazole in Patients with End-Stage Liver Disease
    Wu, Zhenyu
    Jiang, Min
    Yan, Miao
    Li, Guangdi
    Zeng, Zhihao
    Zhang, Xiangling
    Li, Naiping
    Jiang, Yongfang
    Gong, Guozhong
    Zhang, Min
    THERAPEUTIC DRUG MONITORING, 2024, 46 (01) : 89 - 94
12345